Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2014

01-03-2014 | Original Article

Dendritic cells frequency and phenotype in Egyptian type 1 diabetic patients

Authors: Asmaa Mohamad Zahran, Khalid Ibrahim Elsayh, Hekma Saad Farghaly

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2014

Login to get access

Abstract

This study was performed to investigate changes in the dendritic cells (DCs) frequency and phenotype in the peripheral blood in Egyptian Type 1 diabetic children. Also to study the level of B, T lymphocytes, activated T lymphocytes, and costimulatory molecules expression on B lymphocytes. Twenty five children with T1DM and 25 healthy controls were enrolled. Flow cytometric detection of DCs, B-lymphocytes and T-lymphocytes, CD19+CD80+, CD19+CD86+, CD19+HLA-DR+ and CD3+ HLA-DR+ was preformed. The frequencies of monocytoid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs) were significantly decreased in diabetic patients than the controls and the mDCs/pDCs ratio was significantly higher in diabetic patients. The expression of costimulatory molecules CD80 and CD86 on the entire DCs was significantly higher in diabetic children. The frequency of pDCs was negatively correlated with the age in diabetic patients and positively correlated with the level of insulin C-peptide. The percentage of CD80 expressing B lymphocytes and of activated T lymphocytes was significantly higher in the patients. Dendritic cells are reduced in number and display more mature phenotype in T1DM children. The higher expression of CD80 on B lymphocytes and activation of T lymphocytes may reflect the ongoing autoimmune process in this disease. Modulation of the DCs could have beneficial effect in T1DM.
Literature
1.
go back to reference Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev. 1994;15:516–42.PubMedCrossRef Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev. 1994;15:516–42.PubMedCrossRef
2.
go back to reference Skyler JS. Immune intervention for type 1 diabetes mellitus. Int J Clin Pract Suppl. 2011;170:61–70.PubMedCrossRef Skyler JS. Immune intervention for type 1 diabetes mellitus. Int J Clin Pract Suppl. 2011;170:61–70.PubMedCrossRef
3.
go back to reference Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, et al. B cells as key contributors in determining the level of immune responses-B-cell-targeted therapy in patients with autoimmune diseases. Fukuoka Igaku Zasshi. 2005;96:86–92.PubMed Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, et al. B cells as key contributors in determining the level of immune responses-B-cell-targeted therapy in patients with autoimmune diseases. Fukuoka Igaku Zasshi. 2005;96:86–92.PubMed
4.
go back to reference Cox SL, Silveira P. Emerging roles for B lymphocytes in type 1 diabetes. Expert Rev Clin Immunol. 2009;5:311–24.PubMedCrossRef Cox SL, Silveira P. Emerging roles for B lymphocytes in type 1 diabetes. Expert Rev Clin Immunol. 2009;5:311–24.PubMedCrossRef
5.
go back to reference Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271–96.PubMedCrossRef Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271–96.PubMedCrossRef
6.
go back to reference Liu YJ, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol. 2001;2:585–9.PubMedCrossRef Liu YJ, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol. 2001;2:585–9.PubMedCrossRef
7.
go back to reference Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003;18:605–17.PubMedCrossRef Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003;18:605–17.PubMedCrossRef
8.
go back to reference Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol. 2004;173:4433–42.PubMedCrossRef Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol. 2004;173:4433–42.PubMedCrossRef
9.
go back to reference Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CD. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol. 1999;29:2769–78.PubMedCrossRef Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CD. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol. 1999;29:2769–78.PubMedCrossRef
10.
go back to reference Moser M, Murphy KM. Dendritic cell regulation of TH1–TH2 development. Nat Immunol. 2000;1:199–205.PubMedCrossRef Moser M, Murphy KM. Dendritic cell regulation of TH1–TH2 development. Nat Immunol. 2000;1:199–205.PubMedCrossRef
11.
go back to reference Pacanowski J, Kahi S, Baillet M, et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood. 2001;98:3016–21.PubMedCrossRef Pacanowski J, Kahi S, Baillet M, et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood. 2001;98:3016–21.PubMedCrossRef
12.
go back to reference Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183–86.PubMedCrossRef Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183–86.PubMedCrossRef
13.
go back to reference Bauer M, Redecke V, Ellwart JW, et al. Bacterial CpG-DNA triggers activation and maturation of human CD11c−, CD123+ dendritic cells. J Immunol. 2001;166:5000–7.PubMedCrossRef Bauer M, Redecke V, Ellwart JW, et al. Bacterial CpG-DNA triggers activation and maturation of human CD11c, CD123+ dendritic cells. J Immunol. 2001;166:5000–7.PubMedCrossRef
14.
go back to reference Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1:3305–10.CrossRef Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1:3305–10.CrossRef
15.
go back to reference Ruedl C, Bachmann MF, Kopf M. The antigen dose determines T helper subset development by regulation of CD40 ligand. Eur J Immunol. 2000;30:2056–64.PubMedCrossRef Ruedl C, Bachmann MF, Kopf M. The antigen dose determines T helper subset development by regulation of CD40 ligand. Eur J Immunol. 2000;30:2056–64.PubMedCrossRef
16.
go back to reference Boonstra A, Asselin-Paturel C, Gilliet M, et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med. 2003;197:101–9.PubMedCentralPubMedCrossRef Boonstra A, Asselin-Paturel C, Gilliet M, et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med. 2003;197:101–9.PubMedCentralPubMedCrossRef
17.
go back to reference Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.PubMedCrossRef Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.PubMedCrossRef
18.
go back to reference Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes. 2005;54:78–84.PubMedCrossRef Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes. 2005;54:78–84.PubMedCrossRef
19.
go back to reference Vuckovic S, Withers G, Harris M, Khalil D, Gardiner D, Flesch I, et al. Decreased blood dendritic cell counts in type 1 diabetic children. Clin Immunol. 2007;123:281–88.PubMedCrossRef Vuckovic S, Withers G, Harris M, Khalil D, Gardiner D, Flesch I, et al. Decreased blood dendritic cell counts in type 1 diabetic children. Clin Immunol. 2007;123:281–88.PubMedCrossRef
20.
go back to reference World Health Organization. Diabetes Mellitus: report of a WHO Study Group. Geneva, World Health Org. 1985.Tech Rep. Ser., No. 727 World Health Organization. Diabetes Mellitus: report of a WHO Study Group. Geneva, World Health Org. 1985.Tech Rep. Ser., No. 727
21.
go back to reference Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. B cell function in newly-onset type 1 diabetes and immunomodulation with a heat shock protein peptide (DiaPep277): a randomised, doubleblind, phase II trial. Lancet. 2001;358:1749–53.PubMedCrossRef Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. B cell function in newly-onset type 1 diabetes and immunomodulation with a heat shock protein peptide (DiaPep277): a randomised, doubleblind, phase II trial. Lancet. 2001;358:1749–53.PubMedCrossRef
22.
go back to reference Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28:186–212.PubMedCrossRef Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28:186–212.PubMedCrossRef
23.
go back to reference Nikolic T, Welzen-Coppens JM, Leenen PJ, Drexhage HA, Versnel MA. Plasmacytoid dendritic cells in autoimmune diabetes-potential tools for immunotherapy. Immunobiology. 2009;214:791–9.PubMedCrossRef Nikolic T, Welzen-Coppens JM, Leenen PJ, Drexhage HA, Versnel MA. Plasmacytoid dendritic cells in autoimmune diabetes-potential tools for immunotherapy. Immunobiology. 2009;214:791–9.PubMedCrossRef
24.
go back to reference Feili-Hariri M, Morel PA. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetesprone strains. Clin Immunol. 2001;98:133–42.PubMedCrossRef Feili-Hariri M, Morel PA. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetesprone strains. Clin Immunol. 2001;98:133–42.PubMedCrossRef
25.
go back to reference Takahashi K, Honeyman MC, Harrison LC. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol. 1998;161:2629–35.PubMed Takahashi K, Honeyman MC, Harrison LC. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol. 1998;161:2629–35.PubMed
26.
go back to reference Marleau AM, Singh B. Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1- inducing abilities. J Autoimmun. 2002;19:23–35.PubMedCrossRef Marleau AM, Singh B. Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1- inducing abilities. J Autoimmun. 2002;19:23–35.PubMedCrossRef
27.
go back to reference Strid J, Lopes L, Marcinkiewicz J, et al. A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse. Clin Exp Immunol. 2001;123:375–81.PubMedCentralPubMedCrossRef Strid J, Lopes L, Marcinkiewicz J, et al. A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse. Clin Exp Immunol. 2001;123:375–81.PubMedCentralPubMedCrossRef
28.
go back to reference Hinkmann C, Knerr I, Hahn EG, Lohmann T, Seifarth CC. Reduced frequency of peripheral plasmacytoid dendritic cells in type 1 diabetes. Horm Metab Res. 2008;40:767–71.PubMedCrossRef Hinkmann C, Knerr I, Hahn EG, Lohmann T, Seifarth CC. Reduced frequency of peripheral plasmacytoid dendritic cells in type 1 diabetes. Horm Metab Res. 2008;40:767–71.PubMedCrossRef
29.
go back to reference Chen X, Makala LH, Jin Y, Hopkins D, Muir A, Garge N, et al. Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood. Clin Immunol. 2008;129:413–18.PubMedCentralPubMedCrossRef Chen X, Makala LH, Jin Y, Hopkins D, Muir A, Garge N, et al. Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood. Clin Immunol. 2008;129:413–18.PubMedCentralPubMedCrossRef
30.
go back to reference Saxena V, Ondr JK, Magnusen AF, Munn DH, Katz JD. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol. 2007;179:5041–53.PubMedCrossRef Saxena V, Ondr JK, Magnusen AF, Munn DH, Katz JD. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol. 2007;179:5041–53.PubMedCrossRef
31.
go back to reference Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional. Diabetes. 2005;54:78–84.PubMedCrossRef Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional. Diabetes. 2005;54:78–84.PubMedCrossRef
32.
go back to reference Shinomiya M, Fazle Akbar SM, Shinomiya H, et al. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-γ) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol. 1999;117:38–43.PubMedCentralPubMedCrossRef Shinomiya M, Fazle Akbar SM, Shinomiya H, et al. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-γ) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol. 1999;117:38–43.PubMedCentralPubMedCrossRef
33.
go back to reference Feili-Hariri M, Falkner DH, Morel PA. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur J Immunol. 2002;32:2021–30.PubMedCrossRef Feili-Hariri M, Falkner DH, Morel PA. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur J Immunol. 2002;32:2021–30.PubMedCrossRef
35.
go back to reference Sprent J, Webb SR. Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol. 1995;7:196.PubMedCrossRef Sprent J, Webb SR. Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol. 1995;7:196.PubMedCrossRef
36.
go back to reference Clare-Salzler MJ, Brooks J, Chai A, Van Herle K, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest. 1992;90:741.PubMedCentralPubMedCrossRef Clare-Salzler MJ, Brooks J, Chai A, Van Herle K, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest. 1992;90:741.PubMedCentralPubMedCrossRef
37.
go back to reference Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 1995;80:707.PubMedCrossRef Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 1995;80:707.PubMedCrossRef
39.
go back to reference Summers KL, Marleau AM, Stephens TA, Mahon JL, Singh B. Dendritic cells and immunoregulation in the pathogenesis and prevention of type 1 diabetes. Candian Journal of diabetes. 2004;28:20–9. Summers KL, Marleau AM, Stephens TA, Mahon JL, Singh B. Dendritic cells and immunoregulation in the pathogenesis and prevention of type 1 diabetes. Candian Journal of diabetes. 2004;28:20–9.
40.
go back to reference Lagaraine C, Lebranchu Y. Effects of immunosuppressive drugs on dendritic cells and tolerance induction. Transplantation. 2003;75:37S–42S.PubMedCrossRef Lagaraine C, Lebranchu Y. Effects of immunosuppressive drugs on dendritic cells and tolerance induction. Transplantation. 2003;75:37S–42S.PubMedCrossRef
41.
42.
go back to reference Angelini F, Del Duca E, Piccinini S, Pacciani V, Rossi P, Manca Bitti ML. Altered phenotype and function of dendritic cells in children with type 1 diabetes. Clin Exp Immunol. 2005;142:341–46.PubMedCentralPubMedCrossRef Angelini F, Del Duca E, Piccinini S, Pacciani V, Rossi P, Manca Bitti ML. Altered phenotype and function of dendritic cells in children with type 1 diabetes. Clin Exp Immunol. 2005;142:341–46.PubMedCentralPubMedCrossRef
43.
go back to reference Vakkila J, Thomson AW, Vettenranta K, Sariola H, Saarinen-Pihkala UM. Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis. Clin Exp Immunol. 2004;135:455–61.PubMedCentralPubMedCrossRef Vakkila J, Thomson AW, Vettenranta K, Sariola H, Saarinen-Pihkala UM. Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis. Clin Exp Immunol. 2004;135:455–61.PubMedCentralPubMedCrossRef
44.
go back to reference Teig N, Moses D, Gieseler S, Schauer U. Age-related changes in human blood dendritic cell subpopulations. Scand J Immunol. 2002;55:453–7.PubMedCrossRef Teig N, Moses D, Gieseler S, Schauer U. Age-related changes in human blood dendritic cell subpopulations. Scand J Immunol. 2002;55:453–7.PubMedCrossRef
45.
go back to reference Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 1995;80:707–18.PubMedCrossRef Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 1995;80:707–18.PubMedCrossRef
46.
go back to reference Peakman M, Hussain MJ, Millward BA, Leslie RD, Vergani D. Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes. Diabet Med. 1990;7:327.PubMedCrossRef Peakman M, Hussain MJ, Millward BA, Leslie RD, Vergani D. Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes. Diabet Med. 1990;7:327.PubMedCrossRef
47.
go back to reference Gessl A, Walsha¨usl W. Increased CD69 and human leukocyte antigen-DR expression on T-lymphocytes in insulin-dependent diabetes mellitus of long standing. J Clin Endocrionol Metab. 1998;83:2204–09.CrossRef Gessl A, Walsha¨usl W. Increased CD69 and human leukocyte antigen-DR expression on T-lymphocytes in insulin-dependent diabetes mellitus of long standing. J Clin Endocrionol Metab. 1998;83:2204–09.CrossRef
48.
go back to reference Hoffman WH, Helman SW, Passmore G. Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis. J Diabetes Complications. 2001;15:144–9.PubMedCrossRef Hoffman WH, Helman SW, Passmore G. Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis. J Diabetes Complications. 2001;15:144–9.PubMedCrossRef
Metadata
Title
Dendritic cells frequency and phenotype in Egyptian type 1 diabetic patients
Authors
Asmaa Mohamad Zahran
Khalid Ibrahim Elsayh
Hekma Saad Farghaly
Publication date
01-03-2014
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2014
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-013-0143-1

Other articles of this Issue 1/2014

International Journal of Diabetes in Developing Countries 1/2014 Go to the issue